Anúncio
Anúncio

XRTX

XRTX logo

XORTX Therapeutics Inc. Common Stock

0.58
USD
Patrocinado
-0.02
-2.67%
08 de jan., 15:09 UTC -5
Encerrado
exchange

Pós-Mercado

0.59

+0.01
+0.86%

Relatórios de Lucros XRTX

Rácio de surpresa positiva

XRTX separação 4 de 6 últimas estimativas.

67%

Próximo Relatório

Data do Próximo Relatório
30 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
--

XORTX Therapeutics Inc. Common Stock earnings per share and revenue

On 14 de nov. de 2025, XRTX reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, XORTX Therapeutics Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for 30 de mar. de 2026.
Based on -- analistas, XORTX Therapeutics Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio